| mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
-0.02 |
0.9 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |